Stockreport

OKYO Pharma reports improved quality-of-life outcomes in mid-stage eye pain trial [Yahoo! Finance]

OKYO Pharma Limited - American Depositary Shares  (OKYO) 
PDF OKYO Pharma Ltd (NASDAQ:OKYO) said on Wednesday it observed improvements in quality-of-life measures in patients treated with its experimental therapy urcosimod in a mi [Read more]